Chitosan Hemostatic Powder Market Overview
The Chitosan Hemostatic Powder Market is experiencing robust growth, valued at USD 500 million in 2024 and projected to reach USD 1,500 million by 2035. This expansion reflects a compound annual growth rate of 10.6%, driven by increasing demand for advanced wound care and effective bleeding control solutions. Chitosan, a natural biopolymer derived from chitin, offers exceptional...
0 Comments 0 Shares 4 Views 0 Reviews